Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment.

By C. M. Deugarte, A. Bartolucci, R. Azziz. Fertility and Sterility, 2005

605 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. (2009, background): “However, not all women with PCOS have documented insulin resistance by invasive dynamic tests such at the euglycemic clamp (182), the frequently sampled intravenous glucose tolerance test (183), the insulin tolerance test (151), and baseline indices (184).”
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. (2010, background): “Impaired glucose tolerance (IGT) IR occurs in approximately 60–80% of women with PCOS and in 95% of obese women with PCOS (36, 37).”
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis (2011, background): “Insulin resistance and PCOS Many women with PCOS have insulin resistance beyond that predicted by their BMI, with 50–70% of these women demonstrating insulin resistance by various measures”